4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-056411
10% owner sold 13,531 shares at an average $29.17 ($394,635)
From the SEC's structured data for this filing
Trades in this filing
UBS Oncology Impact Fund L.P. · 10% owner
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-14 | Sale : show line 1 in the form | −7,106 | $29.17 | $207,282 | 7,657,817 | D |
| 2021-09-15 | Sale : show line 2 in the form | −6,425 | $29.16 | $187,353 | 7,651,392 | D |
| Open-market sales · 13,531 sh · avg $29.17 · $394,635 | ||||||
Loading xslF345X03/doc4.xml…